Format

Send to

Choose Destination
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):529-30. doi: 10.1016/j.jaip.2015.11.025. Epub 2015 Dec 24.

Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

Author information

1
Department of Medicine, University of Virginia Health System, Charlottesville, Va. Electronic address: TVP9Z@hscmail.mcc.virginia.edu.
2
Department of Medicine, University of Virginia Health System, Charlottesville, Va.
3
Department of Medicine, University of Virginia Health System, Charlottesville, Va; Department of Microbiology, University of Virginia Health System, Charlottesville, Va.
PMID:
26725153
PMCID:
PMC4861669
DOI:
10.1016/j.jaip.2015.11.025
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center